Quantum Biopharma Ltd (QNTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,406 | -28,452 | -24,488 | -12,086 | -8,160 |
| Depreciation Amortization | 951 | 3,901 | 2,933 | 1,966 | 971 |
| Accounts receivable | -53 | 435 | -2,894 | -507 | -448 |
| Other Working Capital | 350 | 807 | 171 | -1,758 | -2,080 |
| Other Operating Activity | 2,673 | 4,179 | 9,919 | 3,168 | 4,223 |
| Operating Cash Flow | $-5,485 | $-19,131 | $-14,360 | $-9,217 | $-5,494 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 6,478 | 6,478 | 6,372 | 5,825 |
| Purchase Sale Intangibles | -500 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -500 | 37 | 37 | 0 | 0 |
| Investing Cash Flow | $-500 | $6,514 | $6,514 | $6,372 | $5,825 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 38,341 | 25,160 | 16,540 | 6,970 | N/A |
| Other Financing Activity | -43 | -987 | -623 | -21 | -11 |
| Financing Cash Flow | $38,299 | $24,173 | $15,916 | $6,948 | $-11 |
| Beginning Cash Position | 17,525 | 5,968 | 5,968 | 5,968 | 5,968 |
| End Cash Position | 49,839 | 17,525 | 14,039 | 10,072 | 6,288 |
| Net Cash Flow | $32,314 | $11,557 | $8,071 | $4,104 | $321 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,485 | -19,131 | -14,360 | -9,217 | -5,494 |
| Free Cash Flow | -5,485 | -19,131 | -14,360 | -9,217 | -5,494 |